Expression and phosphorylation of δ-CaM kinase II in cultured Alzheimer fibroblasts
Dysregulation of calcium homeostasis is among the major cellular alterations in Alzheimer’s disease (AD). We studied Ca 2+/calmodulin-dependent protein kinase II (CaM kinase II), one of the major effectors regulating neuronal responses to changes in calcium fluxes, in cultured skin fibroblasts from...
Saved in:
Published in | Neurobiology of aging Vol. 25; no. 9; pp. 1187 - 1196 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Elsevier Inc
01.10.2004
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Dysregulation of calcium homeostasis is among the major cellular alterations in Alzheimer’s disease (AD). We studied Ca
2+/calmodulin-dependent protein kinase II (CaM kinase II), one of the major effectors regulating neuronal responses to changes in calcium fluxes, in cultured skin fibroblasts from subjects with sporadic AD. We found, by using PCR and Western analysis, that human fibroblasts express the δ-isoform of this kinase, and that CaM kinase II is the major Ca
2+/calmodulin-dependent kinase in these cells. Protein expression level of the kinase was not significantly different in AD fibroblasts. However, the total activity of the kinase (stimulated by Ca
2+/calmodulin) was significantly reduced in AD cell lines, whereas Ca
2+-independent activity was significantly enhanced. The percent autonomy of the kinase (%Ca
2+-independent/Ca
2+-dependent activity) in AD cell lines was 62.8%, three-fold the corresponding percentage in control fibroblasts. The abnormal calcium-independent activity was not due to enhanced basal autophosphorylation of Thr
287. The observed abnormalities, if present in brain tissue, may be implicated either in dysfunction of neuroplasticity and cognitive functions or in dysregulation of cell cycle. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0197-4580 1558-1497 |
DOI: | 10.1016/j.neurobiolaging.2003.12.003 |